首页> 外文期刊>Diagnostic microbiology and infectious disease >Emergence of multidrug-resistant Corynebacterium striatum as a nosocomial pathogen in long-term hospitalized patients with underlying diseases.
【24h】

Emergence of multidrug-resistant Corynebacterium striatum as a nosocomial pathogen in long-term hospitalized patients with underlying diseases.

机译:长期住院的基础疾病患者中,耐多药纹状体棒状杆菌已成为医院内的病原体。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

During a 53-month period (March 1994 to August 1998), 48 Corynebacterium striatum isolates recovered from clinical specimens were characterized. The organisms were identified by both phenotypic characteristics and 16S rRNA gene sequence analysis. Thirty-six (75%) were isolated from sputum/bronchial aspirates, 10 (21%) from wound exudates/pus, 1 (2%) from vaginal discharge, and 1 (2%) from an otorrheic specimen. All 48 patients had been hospitalized for treatment of an underlying disease and had received antibiotics previously. The C. striatum isolates were considered pathogenic based on their abundance within polymorphonuclear neutrophils and their dominant growth in culture. Sensitivities of isolates to 11 antibiotics were determined by broth microdilution. MIC90 values of the isolates were 1 microg/mL for vancomycin, 16 microg/mL for penicillin and ampicillin, 32 microg/mL for minocycline, and > or = 32 microg/mL for cephalosporins, imipenem, ofloxacin, and macrolides. Restriction fragment-length polymorphism analysis with pulsed-field gel electrophoresis was used to determine the clonal identity. The pulse-field gel electrophoresis profiles revealed 14 distinct patterns with 20 subtypes. The isolates for the nosocomial outbreaks of C. striatum included 3 types (A, D, and E) with 4 subtypes (A1, A2, D2, and E). All 4 genotypes had broad-spectrum resistance to antimicrobial agents. Furthermore, type E strain isolated from 3 patients in the same ward was sensitive only to vancomycin. We conclude that C. striatum should be considered an emerging multidrug-resistant nosocomial pathogen in patients hospitalized for a prolonged period and/or in immunocompromised patients with such underlying conditions as cerebrovascular disease, pulmonary disease, diabetes, or malignancy.
机译:在一个53个月的时间(1994年3月至1998年8月)中,鉴定了从临床标本中回收的48株棒状杆菌。通过表型特征和16S rRNA基因序列分析来鉴定生物。从痰/支气管抽吸物中分离出三十六(75%),从伤口渗出液/脓中分离出十(21%),从白带中分离出一(2%),从耳漏标本中分离出一(2%)。所有48例患者均已住院治疗潜在疾病,并且先前已接受抗生素治疗。纹状体梭状芽胞杆菌被认为是致病性的,因为它们在多形核中性粒细胞中的丰度及其在培养物中的优势生长。通过肉汤微量稀释测定分离株对11种抗生素的敏感性。分离株的MIC90值是万古霉素1微克/毫升,青霉素和氨苄青霉素16微克/毫升,米诺环素32微克/毫升,头孢菌素,亚胺培南,氧氟沙星和大环内酯类> 32微克/毫升。用脉冲场凝胶电泳进行限制性片段长度多态性分析来确定克隆身份。脉冲场凝胶电泳图谱显示了14种不同的模式和20种亚型。纹状体梭菌的医院内暴发的分离株包括3种类型(A,D和E)和4种亚型(A1,A2,D2和E)。所有4个基因型对抗菌剂均具有广谱耐药性。此外,从同一病房的3名患者中分离出的E型毒株仅对万古霉素敏感。我们得出结论,对于长期住院的患者和/或患有脑血管疾病,肺部疾病,糖尿病或恶性肿瘤等潜在疾病的免疫功能低下的患者,纹状体梭菌应被视为正在出现的多药耐药的医院内病原体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号